Keyword
in
Collection
Date
to
Download Folder

0 items

Houston Voice, No. 1000, December 24, 1999
File 014
Citation
MLA
APA
Chicago/Turabian
Houston Voice, No. 1000, December 24, 1999 - File 014. 1999-12-24. University of Houston Libraries. University of Houston Digital Library. Web. December 14, 2017. http://digital.lib.uh.edu/collection/montrose/item/6369/show/6353.

Disclaimer: This is a general citation for reference purposes. Please consult the most recent edition of your style manual for the proper formatting of the type of source you are citing. If the date given in the citation does not match the date on the digital item, use the more accurate date below the digital item.

(1999-12-24). Houston Voice, No. 1000, December 24, 1999 - File 014. Montrose Voice. University of Houston Libraries. Retrieved from http://digital.lib.uh.edu/collection/montrose/item/6369/show/6353

Disclaimer: This is a general citation for reference purposes. Please consult the most recent edition of your style manual for the proper formatting of the type of source you are citing. If the date given in the citation does not match the date on the digital item, use the more accurate date below the digital item.

Houston Voice, No. 1000, December 24, 1999 - File 014, 1999-12-24, Montrose Voice, University of Houston Libraries, accessed December 14, 2017, http://digital.lib.uh.edu/collection/montrose/item/6369/show/6353.

Disclaimer: This is a general citation for reference purposes. Please consult the most recent edition of your style manual for the proper formatting of the type of source you are citing. If the date given in the citation does not match the date on the digital item, use the more accurate date below the digital item.

URL
Embed Image
Compound Item Description
Title Houston Voice, No. 1000, December 24, 1999
Contributor
  • Hennie, Matthew A.
Publisher Window Media
Date December 24, 1999
Language English
Subject
  • LGBTQ community
  • LGBTQ people
  • Gay liberation movement
Place
  • Houston, Texas
Genre
  • newspapers
Type
  • Text
Identifier OCLC: 31485329
Rights In Copyright: This item is protected by copyright. Copyright to this resource is held by the creator or current rights holder, and the resource is provided here for educational purposes. It may not be reproduced or distributed in any format without permission of the copyright owner. Users assume full responsibility for any infringement of copyright or related rights.
Note This item was digitized from materials loaned by the Gulf Coast Archive and Museum (GCAM).
Item Description
Title File 014
Transcript HOUSTON VOICE • DECEMBER 24, 1999 13 ■^.y 7&>*-? / £-vt<*r YV Ccu/L ^cLuecLie LucLe. HIV VLll£ CLll|_2 rfW'Af^t*^!^ /^jlS!c*<^S ee. someone just did! ' SUSTIVA' is the first HIV drug approved to be taken once-a-day as part of your combination therapy. Just take three 200 mg capsules together once daily, with or without food; high fat meals should be avoided,Your doctor may suggest taking SUSTIVA at bedtime to reduce any side effects you may experience. SUSTIVA, an NNrVFT, must be used in combination with other HIV drugs. SUSTIVA is tough on HIV. It reduces the amount of virus in your blood and increases the number of CD4 cells. SUSTIVA can even be used in young children, 3 years of age or older. This is based on results from controlled clinical trials at 24 weeks. Presently, there are no results from controlled clinical trials showing the long-term effects of SUSTIVA. SUSTIVA has manageable side effects. Most side effects Are mild to moderate and can be managed.The most significant side effects associated with SUSTIVA therapy have been nervous system symptoms (dizziness, trouble sleeping, drowsiness, trouble concentrating and/or abnormal dreams) and rash. These usually subside within the first two to four weeks of treatment. In a small number of patients, rash may be serious. Taking SUSTIVA at bedtime may help make nervous system symptoms less noticeable. •NNRTI - non-nudeoside reverse transcriptase inhibitor For more information on SUSTIVA. call I -BWMPHARMA or vWt our website at http://www.susiiva.com For more information on the updated DHHS Guidelines, a PDF file of the guidelines is available at http://www hivatis org Now listed among preferred anti-HIV drugs in government guidelines.1 Once Daily SUSTIVA efav i re n z Pregnancy should be avoided in women receiving SUSTIVA because birth defects have been seen in primates dosed with SUSTIVA Barrier contraception should always be used in combination with other methods of contraception. Talk to your doctor when you start taking SUSTIVA. SUSTIVA may change the effect of other medicines {including ones for HIV). Always tell your doctor if you are taking, starting or changing any prescription or non-prescription medicine when taking SUSTIVA. Your doctor may change your medicines or change their dose. You should discuss your prior medical conditions (such as mental illness, substance abuse, hepatitis, etc.) with your doctor before taking SUSTIVA. We know that coping with HIV is difficult enough,Your treatment doesn't have to be. Ask your doctor about SUSTIVA. For more important information see the next page for Patient Information about SUSTIVA. FOR HIV Finally, a once dally medication to treat HIV. SUSTIVA. It's about time. www.sustlva.com I GuidHiwfortheUseofAritiretrovirarAgent^ ' H ■'-aotescents. Panel on Clinical I Department of Heal* and Human Services (DHHS). December I99B. " nd the Sunburst Logo are trademarks of DuPont PharmaceuDcals Company. Copyright © 1999 DuPont Pharmaceuticals Company - 1MAW.VAV.U DuPom Pharmaceuticals
File Name uhlib_31485329_n1000_013.jpg